J Knee Surg 2012; 25(01): 037-044
DOI: 10.1055/s-0031-1286194
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Methicillin-Resistant Staphylococcus Aureus Screening in Total Joint Arthroplasty: A Worthwhile Endeavor

Contributor(s):
Nitin Goyal
1   Department of Orthopaedic Surgery, The Rothman Institute, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
,
Vinay Aggarwal
1   Department of Orthopaedic Surgery, The Rothman Institute, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
,
Javad Parvizi
1   Department of Orthopaedic Surgery, The Rothman Institute, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
› Author Affiliations
Further Information

Publication History

16 June 2011

18 June 2011

Publication Date:
04 October 2011 (online)

Abstract

Infections with methicillin-resistant Staphylococcus aureus (MRSA) are an ever growing problem in the community, hospitals, and for orthopedic surgeons in particular. A conscious effort must be made to deal with this pathogen prior to total joint arthroplasty procedures. The drastic increase in prevalence of surgical-site infections (SSIs) after total joint replacement surgery has proved to be a major health care burden for both patients and surgeons from both a medical and financial standpoint. The development of screening techniques for detection of MRSA colonization in patients being admitted to hospitals is steadily increasing popularity. Particularly nasal swab rapid polymerase chain reaction detection of MRSA allows surgeons to identify patients at high risk for postoperative SSI. A variety of treatment regimens for eradication of MRSA colonization from the nares of surgical patients have surfaced, such as topical mupirocin prior to undergoing surgery. Decolonization of MRSA in patients undergoing joint arthroplasty procedures has demonstrated encouraging initial results in preventing SSIs and should be a serious focus of the future for orthopedic surgeons.

 
  • References

  • 1 National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32 (8) 470-485
  • 2 Schaberg DR. Resistant gram-positive organisms. Ann Emerg Med 1994; 24 (3) 462-464
  • 3 Hidron AI, Edwards JR, Patel J , et al; National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29 (11) 996-1011
  • 4 Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 2005; 11 (6) 928-930
  • 5 Gorwitz RJ, Kruszon-Moran D, McAllister SK , et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008; 197 (9) 1226-1234
  • 6 Barber M. Methicillin-resistant staphylococci. J Clin Pathol 1961; 14: 385-393
  • 7 Benner EJ, Kayser FH. Growing clinical significance of methcillin-resistant Staphylococcus aureus. Lancet 1968; 2 (7571) 741-744
  • 8 Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39 (3) 309-317
  • 9 Schwarzkopf R, Takemoto RC, Immerman I, Slover JD, Bosco JA. Prevalence of Staphylococcus aureus colonization in orthopaedic surgeons and their patients: a prospective cohort controlled study. J Bone Joint Surg Am 2010; 92 (9) 1815-1819
  • 10 Kenner J, O'Connor T, Piantanida N , et al. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol 2003; 24 (6) 439-444
  • 11 Albrich WC, Harbarth S. Health-care workers: source, vector, or victim of MRSA?. Lancet Infect Dis 2008; 8 (5) 289-301
  • 12 Deleo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010; 375 (9725) 1557-1568
  • 13 Giannoudis PV, Parker J, Wilcox MH. Methicillin-resistant Staphylococcus aureus in trauma and orthopaedic practice. J Bone Joint Surg Br 2005; 87 (6) 749-754
  • 14 Patel A, Calfee RP, Plante M, Fischer SA, Arcand N, Born C. Methicillin-resistant Staphylococcus aureus in orthopaedic surgery. J Bone Joint Surg Br 2008; 90 (11) 1401-1406
  • 15 Graham III PL, Lin SX, Larson EL. A U.S. A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med 2006; 144 (5) 318-325
  • 16 Rozgonyi F, Kocsis E, Kristóf K, Nagy K. Is MRSA more virulent than MSSA?. Clin Microbiol Infect 2007; 13 (9) 843-845
  • 17 Wang R, Braughton KR, Kretschmer D , et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007; 13 (12) 1510-1514
  • 18 Kobayashi SD, DeLeo FR. An update on community-associated MRSA virulence. Curr Opin Pharmacol 2009; 9 (5) 545-551
  • 19 Fridkin SK, Hageman JC, Morrison M , et al; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352 (14) 1436-1444
  • 20 Haley RW, Culver DH, White JW, Morgan WM, Emori TG. The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol 1985; 121 (2) 159-167
  • 21 Lee J, Singletary R, Schmader K, Anderson DJ, Bolognesi M, Kaye KS. Surgical site infection in the elderly following orthopaedic surgery. Risk factors and outcomes. J Bone Joint Surg Am 2006; 88 (8) 1705-1712
  • 22 Prokuski L. Prophylactic antibiotics in orthopaedic surgery. J Am Acad Orthop Surg 2008; 16 (5) 283-293
  • 23 Price CS, Williams A, Philips G, Dayton M, Smith W, Morgan S. Staphylococcus aureus nasal colonization in preoperative orthopaedic outpatients. Clin Orthop Relat Res 2008; 466 (11) 2842-2847
  • 24 National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998. Am J Infect Control 1998; 26 (5) 522-533
  • 25 Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351 (16) 1645-1654
  • 26 Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 2001; 33 (Suppl. 02) S94-S106
  • 27 Berbari EF, Hanssen AD, Duffy MC , et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998; 27 (5) 1247-1254
  • 28 Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008; 23 (7) 984-991
  • 29 Florman S, Nichols RL. Current Approaches for the Prevention of Surgical Site Infections. Am J Infect Dis 2007; 3 (1) 51-61
  • 30 Blumberg HM. Community-acquired versus healthcare-associated methicillin-resistant (MRSA) infections: is the distinction blurring?. Clinical Updates in Infections Disease 2009; 12 (1) 1-6
  • 31 Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002; 23 (4) 183-189
  • 32 Hanssen AD, Trousdale RT, Osmon DR. Patient outcome with reinfection following reimplantation for the infected total knee arthroplasty. Clin Orthop Relat Res 1995; 321 (321) 55-67
  • 33 Engemann JJ, Carmeli Y, Cosgrove SE , et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003; 36 (5) 592-598
  • 34 Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis 2003; 9 (2) 196-203
  • 35 Hofmann AA, Kane KR, Tkach TK, Plaster RL, Camargo MP. Treatment of infected total knee arthroplasty using an articulating spacer. Clin Orthop Relat Res 1995; 321 (321) 45-54
  • 36 Berbari EF, Osmon DR, Duffy MC , et al. Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin Infect Dis 2006; 42 (2) 216-223
  • 37 Mittal Y, Fehring TK, Hanssen A, Marculescu C, Odum SM, Osmon D. Two-stage reimplantation for periprosthetic knee infection involving resistant organisms. J Bone Joint Surg Am 2007; 89 (6) 1227-1231
  • 38 Mont MA, Waldman BJ, Hungerford DS. Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection. A comparison-group study. J Bone Joint Surg Am 2000; 82-A (11) 1552-1557
  • 39 Bratzler DW, Houck PM ; Surgical Infection Prevention Guideline Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005; 189 (4) 395-404
  • 40 Hill DA, Herford T, Parratt D. Antibiotic usage and methicillin-resistant Staphylococcus aureus: an analysis of causality. J Antimicrob Chemother 1998; 42 (5) 676-677
  • 41 Marcotte AL, Trzeciak MA. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen in orthopaedics. J Am Acad Orthop Surg 2008; 16 (2) 98-106
  • 42 Dowsey MM, Choong PF. Early outcomes and complications following joint arthroplasty in obese patients: a review of the published reports. ANZ J Surg 2008; 78 (6) 439-444
  • 43 American Academy of Orthopaedic Surgeons Patient Safety Committee. Evans RP. Surgical site infection prevention and control: an emerging paradigm. J Bone Joint Surg Am 2009; 91 (Suppl. 06) 2-9
  • 44 Malinzak RA, Ritter MA. Postoperative wound infection: 35 years of experience. Orthopedics 2006; 29 (9) 797-798
  • 45 Tobin EH. Prosthetic joint infections: controversies and clues. Lancet 1999; 353 (9155) 770-771
  • 46 Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D, de Baere GA. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 2000; 21 (5) 319-323
  • 47 Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10 (3) 505-520
  • 48 Paule SM, Pasquariello AC, Hacek DM , et al. Direct detection of Staphylococcus aureus from adult and neonate nasal swab specimens using real-time polymerase chain reaction. J Mol Diagn 2004; 6 (3) 191-196
  • 49 Tacconelli E, De Angelis G, de Waure C, Cataldo MA, La Torre G, Cauda R. Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis 2009; 9 (9) 546-554
  • 50 Safdar N, Bradley EA. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 2008; 121 (4) 310-315
  • 51 Garrouste-Orgeas M, Timsit JF, Kallel H , et al. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use. Infect Control Hosp Epidemiol 2001; 22 (11) 687-692
  • 52 Yano K, Minoda Y, Sakawa A , et al. Positive nasal culture of methicillin-resistant Staphylococcus aureus (MRSA) is a risk factor for surgical site infection in orthopedics. Acta Orthop 2009; 80 (4) 486-490
  • 53 Kim DH, Spencer M, Davidson SM , et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am 2010; 92 (9) 1820-1826
  • 54 Pofahl WE, Goettler CE, Ramsey KM, Cochran MK, Nobles DL, Rotondo MF. Active surveillance screening of MRSA and eradication of the carrier state decreases surgical-site infections caused by MRSA. J Am Coll Surg 2009; 208 (5) 981-986 , discussion 986–988
  • 55 Muder RR, Brennen C, Wagener MM , et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med 1991; 114 (2) 107-112
  • 56 von Eiff C, Becker K, Machka K, Stammer H, Peters G ; Study Group. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001; 344 (1) 11-16
  • 57 Perl TM, Golub JE. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann Pharmacother 1998; 32 (1) S7-S16
  • 58 Wertheim HF, Vos MC, Ott A , et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004; 364 (9435) 703-705
  • 59 Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM , et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 2002; 35 (4) 353-358
  • 60 Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43 (6) 1412-1416
  • 61 Bode LG, Kluytmans JA, Wertheim HF , et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362 (1) 9-17
  • 62 Darouiche RO, Wall Jr MJ, Itani KM , et al. Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. N Engl J Med 2010; 362 (1) 18-26
  • 63 Wilcox MH, Hall J, Pike H , et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 2003; 54 (3) 196-201
  • 64 Nicholson MR, Huesman LA. Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients. Am J Infect Control 2006; 34 (1) 44-48
  • 65 Hacek DM, Robb WJ, Paule SM, Kudrna JC, Stamos VP, Peterson LR. Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res 2008; 466 (6) 1349-1355
  • 66 Gilpin DF, Small S, Bakkshi S, Kearney MP, Cardwell C, Tunney MM. Efficacy of a standard methicillin-resistant Staphylococcus aureus decolonisation protocol in routine clinical practice. J Hosp Infect 2010; 75 (2) 93-98
  • 67 Otto M. Looking toward basic science for potential drug discovery targets against community-associated MRSA. Med Res Rev 2010; 30 (1) 1-22